Infectious Diseases Society of America

On IDSA’s & HIVMA’s Science Speaks blog: Mahmoud Naser Aldine, MSC, explores how unstudied bacteria could be a natural reservoir for novel antimicrobial compounds and help address antimicrobial resistance. https://lnkd.in/e8n4fxUn

Eliminating the Division of HIV Prevention at the Centers for Disease Control and Prevention would come at a cost to human lives. Cutting off the funding and the technical assistance that state health departments and community-based providers across the country rely on for HIV education, HIV testing and pre-exposure prophylaxis, or PrEP, programs would have devastating health and economic consequences. The lifetime cost of treating HIV is at least $500,000 per person — avoidable costs with the prevention tools available today. Rather than ending HIV as an epidemic in our country, this decision would set us back decades at the expense of American lives and the public health of our communities. — Colleen Kelley, MD, MPH, FIDSA — Chair, HIV Medicine Association

Viral blips have been associated with larger reservoir size and slower decay. In CID, Trevor A Crowell, MD, PhD, and colleagues investigate whether antiretroviral therapy (ART) initiation may decrease the risk of blips. https://lnkd.in/eg3tSew6

New #LetsTalkHIV podcast! Anna Person, MD, discusses threats to the Medicaid program and how they could impact people with HIV with Kate McManus, MD, MSc, FIDSA, Associate Professor of Medicine at the University of Virginia in the Division of Infectious Diseases and International Health and Amy Killelea, JD, Assistant Research Professor at the Georgetown University Center on Health Insurance Reforms (CHIR) and consultant to the HIV Medicine Association. Available on all podcast apps. Search “Let’s Talk ID.” Transcript: https://lnkd.in/enAftieB

IDSA member Allison Agwu, MD, ScM, FAAP, FIDSA, at this year's #StandUpForScience rally in Washington, D.C.

Public health outcomes will continue to sink if health equity is deprioritized, warns IDSA Board member Matifadza Hlatshwayo Davis, MD, MPH, FIDSA, adding, “it will have a domino effect on everyone.” Our press briefing addresses outbreak threats, funding challenges and the effects of misinformation in public health: https://lnkd.in/ec3d-Bkg

Help shape the future IDSA and HIVMA. ? Apply for an open officer or director position on IDSA’s Board of Directors by Thursday, March 27: https://bit.ly/3Fo2Wnv

IDSA is proud to celebrate the 33 extraordinary individuals accepted into the Leadership Institute’s 2025 Community of Leaders program. Congratulations to each member of the new class on their dedication to leadership development and community building in the field of ID/HIV! Learn more about IDSA’s leadership development programs: https://lnkd.in/e2GAascE #FutureofID

IDSA and HIVMA members from across the country gathered on Capitol Hill yesterday to educate their Members of Congress on issues impacting public health and the field of infectious diseases. Topics discussed included antimicrobial resistance, strengthening the ID workforce, and the importance of protecting public health and biomedical research. As ID and HIV experts, your voice has never been so critical. Join IDSA's and HIVMA's MAP program and advocate with your colleagues on issues impacting the ID and HIV landscape: idsociety.org/map

IDSA member Dial Hewlett Jr., MD, FIDSA, of Westchester County Department of Health expresses concerns about the cancelation by CDC of important vaccine meetings. "We at the local level look to our [CDC] and committees like the ACIP to guide us with regard to vaccines." Our press briefing addresses outbreak threats including #birdflu, funding challenges and the effects of misinformation in public health: https://lnkd.in/ec3d-Bkg